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Abstract 
 
Mycobacterium tuberculosis is responsible for nearly 2 million deaths yearly. Upon 
inhalation, mycobacteria are engulfed by alveolar macrophages.  These cells produce 
reactive oxygen and nitrogen intermediates (ROI’s and RNI’s), which normally kill 
pathogens, but are ineffective against invading mycobacteria. What ensues, is the 
formation of a tubercle to sequester the infected macrophages, and the initiation of a 
latent tuberculosis infection, in which the mycobacteria enter a state of non-replicative 
persistence (NRP).  Glutathione (GSH), a host tripeptide thiol-based detoxification 
molecule, protects host cells from ROI/RNI toxicity. Recently, it has been demonstrated 
that GSH is toxic to in vitro and early infection mycobacteria, but no studies determined 
whether GSH is toxic to latent mycobacteria. To further elucidate the impact of GSH on 
mycobacteria, we exposed mid-logarithmic (mid-log) and NRP-induced M. bovis-BCG to 
glutathione in its reduced (GSH), oxidized (GSSG), and nitric oxide associated (GSNO) 
forms, for five days. We have demonstrated that the growth of mid-log M. bovis-BCG 
(BCG) is inhibited by 4 mM GSH, and killed by 8 mM GSH. The growth of NRP 
mycobacteria exposed to 4 mM GSH was inhibited similar to that of unexposed NRP 
mycobacteria. In contrast, the growth of NRP BCG is stimulated four fold following 
exposure to 8 mM GSH. We conclude that exposure of NRP BCG to 8 mM GSH 
stimulates exit from the NRP state into an actively metabolizing state. 4 and 8 mM GSSG 
and GSNO inhibited the growth of mid-log BCG; however, NRP BCG exposed to GSSG 
and GSNO inhibited growth similar to that of unexposed NRP BCG. These results were 
confirmed by performing viability studies, and analysis of free-intracellular cytoplasmic 
ATP concentrations. Initially hypothesized, the toxicity to GSH was due to redox 
potential imbalances within mycobacterial cytoplasm. Mycobacteria contain MSH 
detoxification system (5), to cope with GSH. However, the mechanism of interaction 
between the activation of the system and growth inhibition in mycobacteria is poorly 
understood. HPLC analyses on mid-log and NRP BCG cytoplasms exposed to 4 and 8 
mM GSH demonstrated that the activation of the detoxification system and the oxidative 
stress of the mid-log and NRP cytoplasms were similar. This suggests that the activation 
of the detoxification system and the oxidative state of the mycobacterial cytoplasm may 
not play a direct role in mycobacterial growth inhibition and/or exit from the NRP state.    
 
 
Introduction 
 
Currently, one third of the world’s population is infected by Mycobacterium tuberculosis, 
the causative agent of tuberculosis. The organism is responsible for nearly 2 million 
deaths per year. Although these ratios are not predominant in the United States, 
underdeveloped countries primarily contribute the increase in the number of deaths per 
year. This is attributed to the lack of antibiotics accessibility to antibiotics, as well as the 
rise of antibiotic resistant strains. In relation to the infection, a small percent of the 
infected population is able to clear the infection and be asymptomatic. Majority of 
patients infected with tuberculosis are either in active or latent infection.  
 
Innate Immune Response 
Upon inhalation of M. tuberculosis aerosols from an infected individual, the primary site 
of infection resides within the inner lining of the lungs. Present resident alveolar 
macrophages engulf the bacilli and isolate them within the phagosome. Within the 
phagosome, reactive nitrogen intermediate (RNI) and reactive oxygen intermediates 
(ROI) are introduced to the bacteria, creating a toxic environment aimed to kill the 
pathogen (2). These intermediates are used to perturb the oxidative balance of the 
invading microorganism, leading to cell death. Additional defense abilities of the 
macrophage include acidification of the phagosome, and phagosome fusion with the 
lysosome (37). These acidification processes, are aimed to destroy internal structures and 
proteins of the bacteria, leading to cell death. M. tuberculosis is able to evade this innate 
immune response by initiating factors that inhibit acidification by preventing 
phagolysosomal fusion (1). In addition, they are able to overcome the oxidative stress 
introduced by the host by using catalase/peroxidase enzyme (KatG) (23), superoxide 
dismutase (43), and a thiol-based detoxification system (36). Collectively, these factors 
assist the bacteria to evade multiple components of the host immune response, allowing 
them to persist, and replicate within the macrophage.  
 
Bacilli that are able to elude the adverse oxidative effects and phagosomal acidification 
processes continue to multiply logarithmically for approximately two weeks after initial 
infection inside the macrophage. At this point macrophages release chemokines and 
interferon-γ (IFNγ) to actuate T-cell immunity and antigen-specific T lymphocytes, 
which further activate the macrophages to kill the bacteria. However, this specific cell 
mediated immune response is unable to eliminate the pathogen from the host, leading to 
the formation of a granulomatous region called a tubercle; initiating latent infection (37). 
Chemokines and cytokines are produced by infiltrating leukocytes and local tissue to 
maintain the formation of the tubercle (35). The infiltration of these intermediates, at 
increased concentrations, creates a central region of necrotic tissue within the granuloma; 
the mycobacteria in turn use this necrotic tissue for nutrients (35). In the core of the 
granuloma, the reactive nitrogen, oxygen, and other toxic immune components create an 
hypoxic environment which leads to the formation of necrotic tissue. The coupling of 
these two mechanisms limits the metabolic capabilities of the bacteria, in addition to 
limiting the amount of available nutrients for the bacteria, over time. As a result, there are 
changes in gene expression that force the bacteria into latent Tb infection (LTBI) (30).  
 
Studies performed my Wayne et al. (2001) show that the transition to latent infection 
occurs in successive stages, which are O2 dependent. The gradual depletion of oxygen 
leads to nonreplicative persistence (NRP) state that is characterized by bacteriostasis, 
metabolic, chromosomal, and structural changes in quiescent bacteria. In addition, the 
NRP state is characterized by a shift from rapid to slow growth, significantly reduced 
metabolic activity, followed by a complete shutdown of cell cycle progression (12). An 
adaptive process associated with the NRP state in M. tuberculosis is the Dos-response 
(DosR). Activation of this response allows the bacteria to enter the NRP state in order to 
withstand extended alternative growth conditions, such as those present in the host (12).  
 
DosT/S/R 
In order to stimulate the latent NRP state in vivo in murine models, the bacteria require 
the factors interferon- γ, tumor necrosis factor, or nitric oxide (4). When initiating latency 
in vitro, the dormant state can be established by nutrient deprivation (4) and oxygen 
depletion (40). In addition, low, non-toxic concentrations of NO are able to induce 
dormancy in mycobacteria (38). Specifically, the NO competes with O2 to bind to DosR, 
inducing 48 latency genes. The DosR regulon is expressed when exposed to nontoxic 
concentrations of NO and CO, and the induction of the regulon is inhibited in the 
presence of oxygen (3, 19, 20, 28, 29, 31, 32, 34, 38, 42). Two important signal 
regulators DosT and DosS autophosphorylate, then transfer a phosphate to the DosR 
regulon, activating DosR (27). Both the DosT and DosS sensors are bound to heme 
groups that bind to the activating or deactivating divalent gasses: NO, CO, and O2. The 
interactions of the divalents with the heme group are responsible for ultimately activating 
and deactivating DosR (6, 19, 28, 29, 33). DosT is identified to be the hypoxia sensor; 
when oxygen is bound to DosT the activation of DosR is inhibited. When the heme group 
present on the DosS receptor is oxidized in the presence of high oxygen concentrations, 
DosR sensor is rendered inactive. DosS however is the redox sensor, once the heme 
group on the sensor is reduced to Fe2+ from Fe3+, signaling for DosR activation occurs (6, 
19). It is possible for NO and CO to displace O2 from the DosS and DosT heme groups, 
resulting in activation of DosR (6, 21). Due to the high binding affinities of NO and CO 
to the iron present in the heme group, they are capable of locking the DosR sensor in the 
active state. Overall, the induction and maintenance of NRP due to DosR activation is 
dependent on the presence and concentration of CO and NO  
  
Glutathione 
Simultaneous to the production of ROIs and RNIs, the cells of the immune response 
produce glutathione (GSH), a component of the host thiol-based detoxification system. 
GSH is a tripeptide comprised of γ-glutamate, cysteine, and glycine, which functions as 
an antioxidant found in all cells of the body, including macrophages (9). Glutathione 
protects phagocytic host cells from oxidative toxicity associated with the release of ROIs 
and RNIs, chemokines, and cytokines, by maintaining a reduced environment within the 
host cytoplasms (36). The intracellular host concentration of GSH is approximately 1-8 
mM, and is 1000 fold higher than the plasma concentration, which is approximately 5-50 
µM (11, 16). During oxidative stress, GSH is oxidized to glutathione thiodisulphide 
(GSSG); GSSG is converted back to GSH by GSH reductase; a NADPH-cofactor 
requiring conversion (11, 16). In contrast to GSH, GSSG acts to maintain a reduced 
environment for in organellic structures within the host macrophage. In addition, GSH 
can react with NO to form S-nitrosoglutathione (GSNO); the stability of NO is increased 
once bound with GSH (9). During initial infection, GSNO serves as an NO donor to 
interfere with the pathogenesis of invading microorganisms including mycobacteria (10, 
25). GSNO has been shown to be responsible for killing M. tuberculosis in mice (15).  
 
GSH can be transported into the bacterial cell as a tripeptide, dipeptide, or single amino 
acids using ABC oligopeptide transporters (Opp) (7). Exoenzymes secreted by Mtb are 
able to break down GSH into it a dipeptide, and into its individual amino acids. The 
action of the exoenzyme γ-glutamyl transpeptidase (GgtA), GSH is cleaved into cys-gly 
and γ-glutamate (10, 22). Cys-Gly is transported into the cell by an ABC transporter 
dipeptide permease (Dpp) (9). Although in-depth analyses have been performed, the 
mechanism of GSH toxicity in mycobacteria is still unknown. A prevalent theory 
suggests that an imbalance is created in the mycobacterial thiol detoxification system 
(mycothiol), leading to an oxidation/reduction imbalance, resulting in cell death (26). 
This imbalance is created due to the import of cys-gly into the mycobacteria cell (9).  
 
Bacterial Mycothiol (MSH) 
Bacterial mycothiol (MSH) is the major low-molecular-mass thiol present in 
mycobacteria. MSH is found only in actinomycetes, and at high concentrations in 
Mycobacterium tuberculosis. The functionality of mycothiol is analogous to that of 
mammalian thiol based detoxification system – glutathione. It is known that glutathione 
is not present in Mtb. Therefore, similar to glutathione; mycothiol acts to maintain the 
oxidative state of the mycobacterial cell; by interconverting between MSH and MSSM. 
Mycothiol activity protects M. tuberculosis from toxic oxidants produced by antibiotics 
and the macrophage itself, such as ROIs and RNIs (5). An alteration in mycothiol activity 
is shown to alter the overall oxidation state of the bacterial cell. Specifically, an altered 
oxidation state can influence the cell wall components altering the cell wall permeability, 
leading to greater molecule exchange between extracellular and intracellular components 
and bacterial cell death (5). By evaluating the oxidative balance of mycothiol upon 
exposure to toxic concentrations of glutathione will help elucidate the function of 
glutathione. 
 
Primary Focus 
It has recently been demonstrated that both GSH and GSNO are toxic to mycobacteria 
both in vitro and in vivo early infection models (prior to the formation of the tubercle) 
(9).  GSNO toxicity is likely due to the mycobactericidal effects of NO release from 
GSNO (7).  It has been hypothesized that the toxicity to GSH results from a redox 
potential imbalance in the mycobacterial cytoplasm leading to growth inhibition.  In vitro 
studies have demonstrated that M. tuberculosis uses MSH to cope with both GSH and 
GSNO (2) but, the underlying mechanisms surrounding the balance between the 
activation of this system and mycobacterial killing in vitro and in vivo early infection 
models is poorly understood.  In addition, there have been no studies to determine if GSH 
and GSNO are toxic to mycobacteria residing within the tubercle during latent infection. 
In order to further confirm previous studies and continue investigation of M. tuberculosis 
in the NRP state, both mid-logarithmic and NRP cells were treated with GSH, GSSG, and 
GSNO, over five days, at concentrations of 4 mM and 8 mM concentrations; these 
concentrations mimic GSH levels present within the alveolar macrophage. We performed 
growth studies supplemented with the cell viability assays, and intracellular free ATP 
concentration assays to determine the bacteriostatic and bactericidal effects of each 
glutathione derivative at the varying concentrations. HPLC analysis was performed to 
investigate the impact of glutathione on the oxidative state of the mycobacterial 
cytoplasm. 
 
We confirmed that 4 mM GSH is bacteriostatic, and 8 mM GSH is bactericidal to mid-
log M. bovis-BCG over five days. In addition, our results showed that 4 mM and 8 mM 
GSSG and GSNO were bacteriostatic to mid-log M. bovis-BCG over the five-day period. 
NRP BCG exposed to 4 mM GSH, and 4 mM and 8 mM GSSG and GSNO showed no 
significant impact on the growth of NRP BCG. Surprisingly, 8 mM GSH with NRP BCG 
showed an increase in growth, suggesting exit from the NRP state. HPLC analysis 
confirms that stimulated growth is not due to an imbalance in the oxidative state of the 
mycobacterial cytoplasm. Our new hypothesis suggests that the transition from NRP to 
mid-log is due to cellular signaling, resulting in a deactivation of the DosR system due to 
the binding of oxygen to the DosT receptor.  
 
Material and Methods 
 
Bacterial Strains and Growth 
M. bovis-BCG Pasteur strain was grown in Middlebrook medium. Middlebrook 7H9 (liquid) and 
7H11 (1.5% agar) media (Sigma) were supplemented with glycerol (0.5%, vol/vol) and ADC 
supplement (0.5% albumin – from bovine serum [Sigma], 0.2% dextrose, 0.85% NaCl). All 
liquid cultures of BCG were supplemented with 0.05% Tween 80 (Sigma). All cultures were 
incubated in a rotating incubator at 37°C 
 
Mid-log BCG cells were inoculated in in 7H9 supplemented with glycerol (0.5%, vol/vol) and 
ADC supplement (0.5% albumin – from bovine serum [Sigma], 0.2% dextrose, 0.85% NaCl). 
The non-replicating persistence (NRP) oxygen depletion model developed by Hu and colleagues 
(2003) was replicated to induce NRP BCG (in vitro) cells at 37°C. NRP cells remained 
stationary for 100 days, without agitation, in a low oxygen environment.  
 
M. bovis – BCG Growth Curve 
Five-day growth cultures were inoculated on day 1 with mid-logarithmic BCG or NRP BCG at 
OD600 of 0.1, in 7H9 media with ampicillin (1 mg/mL) in 15 mL sterile conical tubes. 1 mL 
aliquots were removed daily to assess cell density at OD600 over five days. All mid-log BCG 
cultures were incubated in a shaking incubator. All liquid NRP trail cultures were placed in a 
stand still incubator. Sterile glass beads were added to each NRP trail tube to compensate for the 
volume displacement to ensure an anoxic environment. All samples were incubated at 37°C.   
 
Trails consisted of samples at 0 mM, 4 mM, and 8 mM concentrations of GSH, GSSG, and 
GSNO. 4 mM and 8 mM GSH and GSSG were added daily for four days. Samples treated with 
GSNO were inoculated at concentrations of 4 mM, and 8 mM only once, on the initial day. Each 
trail was performed in triplicate.  
 
M. bovis –BCG Inhibition/Killing Viability Assay 
A 10 µL aliquot of each sample was removed while performing the growth curve studies, and 
were diluted by a (1/100,000 serial dilution), and 100 µL were plated on 7H11 agar. Plates were 
incubated at 37°C for 27 days. CFU were quantitated and normalized according to the dilution 
factor.  
 
M. bovis –BCG Cell Intracellular ATP Quantization 
Quantitation of intracellular ATP was performed according to the BacTiter-GloTM Microbial Cell 
Viability Assay [Promega]. Samples were removed daily and diluted to OD600 of 0.1. The 
chemiluminescence of the ATP reaction was determined using a Gel Logic 2200 PRO 
luminometer.    
 
Cell Extraction for Thiols Analysis 
Cell aliquots were taken in triplicates from the growth trails and normalized to OD600 of 0.1. 
Extracts were labeled with monobromobimine (mBBr) for thiol analysis as described in Newton 
et al. (1996). Modifications were made in which cell extracts were micro-centrifuged at 3,000xg, 
10 min, 4 0C; aspiration of the media was performed, and cells were resuspended in 0.500 mL 
inactivation buffer [20 mM HEPES buffer (pH 8.0), 50% ACN, and 2 mM mBBr]. Cells were 
placed at 60 0C for 15 min, and were micro-centrifuged at 21,100xg for 20 min; to pellet cellular 
debris. Supernatants was aspirated, and stored at -80 0C.  
 
HPLC Analyses of Thiol-mB Derivatives 
The thiol bimine derivatives (RSmB) were analyzed using a modified HPLC method 1 (13, 24) 
to provide improved separation of the compounds. A LC 410 pump (Perkin-Elmer, Norwalk, 
CT) coupled to a C-18 10um column (4.5mm x 250mm) at a flow rate of 1 ml min-1 was used 
with buffers A (0.25% acetic acid in H2O titrated to pH 3.6 with NaOH) and buffer B (HPLC 
grade methanol, Fisher). The linear gradient was as follows: 0 min, 10% B; 10 min, 10% B; 25 
min, 18% B; 40 min, 27% B; 50 min, 50% B; 60 min, 100% B; 65 min, 10% B; 75 min, 10% B 
reinject. The retention times are as follows: 2:16 min, γ-glu-cys; 12:12 min, L-cys; 10:48 min, 
cys-gly; 12:12 min, GSH; 18:32 min, MSH. NRP Samples were diluted 1:1 using 
methanesulfonic acid prior to injection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results  
 
M. bovis – BCG GSH Growth Curve 
In order to investigate the effect of glutathione on the growth of BCG, we performed triplicate 
growth trials over five days by exposing BCG to 4 and 8 mM GSH. On Day 1, unexposed, 4 
mM, and 8 mM mid- log and NRP samples were all normalized to an OD600 of 0.1 (Figure 1a). 
Spectrophotometer analyses of bacterial growth over five days upon exposure to GSH shows that 
mid-logarithmic unexposed BCG exponentially grew to reach a maximum OD600 of 0.797 on 
Day 4. Mid-logarithmic BCG exposed to 8 mM GSH show decreased levels in bacterial growth – 
reaching a maximum OD600 of 0.240. Mid-logarithmic BCG exposed to 4 mM GSH over five 
days resulted in similar optical densities to that of unexposed BCG; having a maximum OD600 of 
0.694. These growth studies propose that GSH is toxic to mid-log BCG over five days. However, 
they do not confirm if the cells are being inhibited or killed. 
 
Optical density analyses performed on NRP BCG (Figure 1b) resulted in no significant increase 
in growth of unexposed NRP bacteria. The maximum OD600 reached was 0.131. Similar results 
are shown for NRP BCG exposed to 4 mM GSH over a five-day period. The maximum OD600 
was 0.135. NRP BCG exposed for 8 mM GSH over five days, resulted in a significant increase in 
optical density. On Days 1, 2, and 3 the highest OD600 of 8 mM NRP BCG was 0.125. 
Remarkably, on Day 4 the OD600 increased to 0.207, and on Day 5 the OD600 of 8 mM NRP BCG 
was 0.398. These results suggest that 8 mM GSH facilitates in the exit from the NRP state to 
mid-logarithmic growth.  
  
M. bovis –BCG GSH Inhibition/Killing Viability Assay 
Based off the results obtained from the growth studies, in order to determine whether GSH 
inhibited or killed mid-log and NRP BCG, we performed cell viability assays. On Day 1, 
unexposed, 4 mM, and 8 mM mid- log and NRP samples were all normalized to a bacterial count 
of 1.0 x 108 bacterial cells per mL. The mid-log (Figure 2a) unexposed results show that there is 
an average of 2.5 x 109 total viable cells over five days. Mid-log BCG exposed to 4 mM GSH, 
show there are viable bacterial cells, with a total average cell count of 2.2 x 109 over the five-day 
period. In contrast, mid-log BCG exposed to 8 mM GSH exhibited no colony forming units on 
Day 4 and 5. Viable CFU were quantitated between Day 1 and 3 for mid-log 8 mM GSH 
exposed BCG. On Day 3, mid-log BCG exposed to 8 mM GSH presented an average cell count 
of 3.0 x 109; similar to that of 0 and 4 mM GSH exposed mid-log BCG. The cell viability of 8 
mM GSH exposed mid-log BCG was conducted to investigate the number of viable cells in 
relation to the growth curve pattern. These killing results show to be consistent with the growth 
curve pattern. They confirm that the bacterial cells are indeed being killed over five days.    
 
NRP BCG (Figure 2b) exposed to 4 and 8 mM GSH did not show statistically significant 
deviations in cell count on days 1, 2, 3, and 4. Viability analysis of NRP BCG on Day 5 shows 
an increase in the number of bacterial cells for unexposed, 4 mM GSH, and 8 mM GSH. 
Normalization of the data presented in Figure 2c to an OD600 of 0.1 shows on Day 5 there are less 
viable bacterial cells upon exposure to 8 mM GSH. On Day 5 of the NRP BCG viability trials, 
there were 3.53 x 108 viable unexposed BCG cells; 3.34 x 108 viable 4 mM exposed BCG cells, 
and 9.59 x 107 viable 8 mM exposed BCG cells. The lower viability noted after normalization 
indicates that BCG is exiting the NRP state to mid-log growth. During this transition, GSH then 
kills the BCG, as seen in the mid-log growth trials.    
 
M. bovis – BCG GSH Exposed Intracellular ATP Quantization 
The ATP assays were performed to determine the free ATP present in mid-log cells in 
comparison to NRP to confirm that the NRP state maintains a low metabolic profile, consistent 
with low metabolic energetic needs. Also, by evaluating the free intracellular ATP 
concentrations present within the cells over the five days upon exposure to GSH, we were able to 
confirm the killing of mid-log and NRP BCG. In addition, evaluating the energetics of the cell 
helped elucidate the cellular response upon exposure to glutathione. Normalization of mid-log 
BCG cells (Figure 3a) on Day 1 resulted in an intracellular ATP concentration of 0.108 uM 
(unexposed BCG), 0.117 uM (4 mM GSH exposed), and 0.130 uM – (8 mM GSH exposed). On 
Day 5, unexposed mid-log BCG intracellular ATP concentration reached a maximum of 1.380 
uM. However, over the 5 day period, the ATP concentration was between 0.108 – 1.380 uM. The 
ATP concentration within 8 mM GSH exposed mid-log BCG was between 0.130 – 2.284 uM. 
On Day 3, the ATP concentration of 8 mM GSH mid-log BCG was 1.596 uM; on Day 4 the 
concentration increased to 2.284 uM, and on Day 5, the 8 mM GSH mid-log ATP concentration 
decreased to 0.779 uM. These results suggest that through Day 3 there is an increase in ATP in 
samples treated with 8 mM GSH, in attempts to overcome the toxicity of glutathione. On days 4 
and 5 a decrease in free intracellular ATP is noted due to cell death; confirmed by the cell 
viability assay. This 17.5 fold increase in intracellular free ATP can be explained through two 
perspectives. The first relies on the basis of activation of the bacterial SOS response, in which 
the cell increases its metabolic needs, DNA repair mechanisms, increased protein output, and 
increased cellular respiration in order to overcome the external stress.  
 
For NRP BCG the assay helped determine whether the energetic needs of the cell were increased 
or decreased to facilitate the exit from the NRP state. Intracellular ATP concentration in NRP 
BCG (Figure 3b) was minimal in 8 mM GSH in days 1-5, while unexposed BCG showed 
increased concentrations on day 3, 4, and 5. The initial Day 1 ATP concentration for unexposed 
NRP BCG was 0.017 uM. The following days showed increased levels between 0.746 – 1.698 
uM between days three and five. NRP BCG exposed to 8 mM GSH showed on Day 1, 2, 3, and 4 
to have intracellular ATP concentrations between 0.016 – 0.045 uM. On Day 3, an increase in 
intracellular ATP is noted at 0.197 uM; the maximum over the five day trial. The lack of increase 
in ATP over the five days is suggestive that an upregulation in ATP production is not seen 
because the ATP is being utilized to exit the NRP state.  
 
M. bovis – BCG GSH Exposed HPLC Thiol Analysis 
In order to further investigate the role of GSH with respect to the oxidative state of the 
mycobacterial cytoplasm, we performed thiol HPLC analysis on mid-log and NRP BCG over 
five days. This analysis was used to compare the intracellular levels of GSH, MSH, Cys-Gly, L-
cys, and γ-glutamate. Alterations in these various compounds will elucidate oxidative changes 
that occur due to the direct or indirect interaction of GSH in NRP BCG. Figures 4 a, b, and c, 
show the separation of exposed NRP BCG intracellular compounds based on the Thiol analysis 
as described above. This separation was performed using 0.25% Acetic Acid (pH 4.2) for 
increased separation between cys-gly/L-cys (12;36 min), mixture of GSH, and/or dipeptide cys-
Gly and/or L-cys (14:55 min) and MSH (18:52 min). Due to the relative similarities of GSH, 
cys-gly, and L-cys, complete separation of the peaks for cys-gly, L-cys, and GSH is not shown. 
These results show an increase in base area for cys-gly and L-cys in samples exposed to 8 mM 
GSH (Figure 4a/c). There is an increase in either GSH/cys-gly/L-cys, which over five days gives 
raise to the mixture-defined region. This base widening is noted on Day 5 in all triplicate 
samples of 8 mM GSH NRP BCG. In comparison to unexposed NRP BCG samples (Figure 
4a/b), there is no significant expansion of the mixture-defined region over five days. Which 
suggest that there is no import of GSH, cys-gly, or L-cys into the mycobacterial cell. With 
respect to mycothiol (Figure 4d) the average base area correlating to the concentration of MSH 
in 1 x 108 bacterial cells is not significantly different over the five days when comparing 
unexposed and 8 mM GSH exposed cells. The average base area concentration seen between 
days 1 and 3 is 11,000 – 13,000 units. On Day 4 however, a decrease in mycothiol concentration 
is noted in 8 mM GSH exposed samples. In comparison to the data as a whole, there is no 
significant difference in the mycothiol concentration data represented for both exposed and 8 
mM GSH exposed NRP BCG. These results confirm that there is no significant change in the 
oxidative balance of the mycobacterial cell. However, in NRP BCG exposed to 8 mM GSH, the 
decrease in mycothiol on Day 4 may be attributed to the exit from the NRP state due to GSH and 
oxygen.   
 
M. bovis – BCG GSSG Growth Curve  
Similar to the growth curve of GSH, in order to investigate the effect of oxidized glutathione on 
the growth of BCG, we performed growth triplicate growth trials over five days by exposing 
BCG to 4 and 8 mM GSSG. On Day 1, all culture presented were normalized to an OD600 of 0.1. 
Mid-log BCG exposed to the oxidized glutathione, GSSG (Figure 5a), at concentrations of 4 and 
8 mM shows results similar to that of mid-log BCG exposed to GSH. Unexposed BCG followed 
the exponential mid-logarithmic growth patter, and over the five days increased to an OD600 of 
0.773. Mid-log BCG exposed to 4 mM GSSG, showed limited growth between Days 2-5. An 
OD600 of 0.258 – 0.314 was maintained over that four day period. 8 mM GSSG exposed mid-log 
BCG showed an increase to OD600 of 0.238 on Day 2; and decreased to OD600 of 0.120 on Day 5. 
These results suggest that GSSG is toxic to mid-log BCG, however these studies do not confirm 
cell death or inhibition. To further confirm the toxicity of GSSG, plating assays were performed.  
 
On Day 1, all NRP samples were normalized to an OD600 of 0.1. NRP BCG exposed to GSSG 
(Figure 5b) showed no statistical deviations when exposed to 4 and 8 mM GSSG compared to 
unexposed BCG over five days. Between Day 2-5, the cell density increased to an average OD600 
of 0.249, for unexposed, 4 mM GSSG, and 8 mM GSSG. These growth results suggest that 
GSSG has no effect on the growth of NRP BCG over five days; to validate these results, plating 
assays were performed.  
 
M. bovis –BCG GSSG Inhibition/Killing Viability Assay 
After performing growth studies to evaluate the effects of GSSG on mid-log and NRP BCG, we 
performed cell plating assays to determine whether GSSG inhibited or killed the BCG. The cell 
viability assay for mid-log BCG exposed to GSSG  (Figure 6a) shows an increase in the number 
of viable unexposed bacterial cells present over the five days. Over the five-day trial period, 
there was a maximum of 4.74 x 109 viable unexposed mid-log BCG cells present on Day 4. Mid-
log BCG treated with 4 mM GSSG showed in increase in viable cell count throughout the five 
days, increasing to 5.44 x 109 cells on Day 5. In addition, mid-log BCG exposed to 8 mM GSSG 
showed an increase in viable cell count over the five-day period. The maximum number of viable 
cells is noted on Day 5 to 4.09 x 109 cells. Analysis of these results confirms that both 4 mM and 
8 mM GSSG is capable of inhibiting mid-log BCG, but are unable to kill the bacteria.   
 
NRP BCG cells treated with 4 mM and 8 mM GSSG (Figure 6b) showed a viable number of 
cells over five days. In comparison to unexposed NRP BCG cells, which also showed a viable 
number of cells over five days is comparable to that of GSSG treated cells. Over the five days, 
all three trial types had an average of approximately 2 x 107 viable cells. No significant deviation 
or change is noted in the number of quantifiable bacterial cells in each trial. These results 
confirm that upon exposure to varying concentrations of GSSG, the growth and viability of NRP 
BCG is not affected.  
 
Mid-log and NRP BCG GSSG Exposed Intracellular ATP Quantization 
After confirming the inhibition of mid-log BCG growth upon exposure to GSSG, we performed 
intracellular ATP assays to determine the utilization and accumulation of ATP in the cells over 
five days. Intracellular ATP analysis of mid-log BCG exposed to 4 and 8 mM GSSG (Figure 7a) 
show to have similar trends in intracellular ATP concentrations over five days; consistent with 
that of unexposed mid-log BCG. On Day 1, the average intracellular concentration of unexposed, 
4 mM GSSG exposed, and 8 mM GSSG exposed was 0.091 uM. Unexposed mid-log BCG 
presented an average intracellular ATP concentration of 1.308 uM on Day 4, and 1.149 uM on 
Day 5. 4 mM GSSG exposed mid-log BCG presented increased intracellular ATP concentrations 
on Day 2 (0.336 uM), Day 3 (1.029 uM), and Day 4 (1.773 uM). A decrease to 1.294 uM was 
noted on Day 5 in comparison to Day 4. When mid-log BCG is treated with 8 mM GSSG, an 
increase in intracellular ATP is presented through Day 4. Similar to that of 4 mM GSSG, a 
significant decrease in intracellular ATP concentrations is noted. Between Day 1 and 4, the 
intracellular ATP concentration increases from 0.091 uM to 2.097 uM; and on Day 5 the 
intracellular concentration is reduced to 1.294 uM.  
 
With respect to NRP BCG exposed to varying concentrations of GSSG, we performed the 
intracellular ATP assay to determine that the NRP BCG cells are indeed viable, in addition to the 
BCG remaining in the NRP state and utilizing the same amount of ATP as unexposed NRP 
BCG. NRP BCG exposed to GSSG exhibit decreased intracellular ATP concentrations in 
comparison to mid-log BCG exposed to GSSG (Figure 7b). Unexposed NRP BCG on Day 1 
presented an intracellular ATP concentration of 0.017 uM. A significant increase is noted on Day 
(0.476 uM), and Day 5 (0.697 uM), which is maintained into Day 5 (0.553 uM). NRP BCG 
exposed to 4 mM GSSG shows to have an increase in ATP over four days; 0.024 uM - 0.886 uM. 
On Day 5, a decrease is noted to 0.633 uM. In comparison to unexposed and 4 mM GSSG 
treated, 8 mM GSSG treated cells exhibited the greater free intracellular ATP concentrations. On 
Day 1, the concentration was 0.016 uM; a significant increase is occurs on Day 3 (0.683 uM), 
and a maximum on Day 4 (1.079 uM). A decrease in intracellular ATP concentration is noted on 
Day 5 (0.547 uM) by a factor of 1.97. Upon evaluation of cell energetics, all samples resulted in 
similar free ATP values over the five-day period. Taken together, these results confirm that the 
growth of NRP BCG is not affected by the exposure to GSSG.  
 
 
 
M. bovis – BCG GSNO Results 
In order to further investigate the effect of the final glutathione derivative, GSNO, we performed 
growth studies, cell viability plating, and intracellular ATP assays to determine its effects on 
mid-log and NRP BCG. Although not presented, mid-log and NRP BCG was exposed to 4 and 8 
mM GSNO, over a five day period. These growth studies were evaluated similarly to that of 
GSH and GSSG. The growth curve, cell viability assay, and intracellular ATP assay results did 
not show statistically varying data when compared to that of GSSG. Figures 5, 6, and 7 can attest 
to the data presented by the GSNO studies. In addition, HPLC thiol analysis upon exposure to 
GSSG and GSNO has not been completed. The results from all three assays confirm that GSNO 
is only capable of inhibiting mid-log BCG cell growth, and has no effect on the growth and 
replication of NRP BCG. 
Discussion 
 
Influence of GSH on Mid-log and NRP BCG   
Four distinct phases characterize the growth of bacteria over a period of time. These successive 
stages define the growth curve, which consists of a lag, log, stationary, and decline phases. Our 
results show that the mid-log BCG unexposed bacteria exhibit mid-logarithmic growth with 
approximately an eight-fold increase in optical density over the five days. This was similar to 
Mid-log BCG exposed to 4 mM GSH (Figure 1a). After evaluating the viability tests (Figure 2a) 
to confirm the bacteriostatic effects of 4 mM GSH, we conclude that M. bovis-BCG is capable of 
detoxifying 4 mM GSH, and is not detrimental to its growth. This is supported by the presence of 
quantified viable CFU over the five-day period. In addition, when evaluating the energetics of 
unexposed and 4 mM GSH exposed bacilli (Figure 3a), both cell trials followed similar patterns 
of ATP utilization over the five days. This data suggests that M. bovis-BCG growth is not 
inhibited by 4 mM GSH. 
 
The growth of mid-log BCG was completely halted upon exposure to 8 mM GSH over five days 
(Figure 1a). The viability data shows quantifiable colony forming units on days 1, 2, and 3. 
However, in support of 8 mM GSH being toxic to BCG, there are no quantifiable colony forming 
units on days 4 and 5. The intracellular free-ATP quantization assay (Figure 3a) shows that there 
is a 17.5 fold increase in free intracellular ATP by Day 4. An up-regulation in genes and systems 
controlling these aspects of the cell, require an influx of free ATP. Therefore, over the four-day 
period, the cells are attempting the overcome the stress implemented by toxic levels of GSH. The 
second perspective emphasizes that toxicity due to GSH has already killed the bacterial cells. 
However, the cells have not lysed, resulting in an accumulation of ATP. The decrease in ATP 
levels on Day 5 can be explained by the lack of bacterial growth and replication due to consistent 
exposure to toxic concentrations of GSH. Although these three analyses collectively confirm that 
8 mM GSH does kill mid-logarithmic, they fail to propose a definitive explanation as to how 
GSH is able to kill the cells. Previous studies have assessed the interaction of GSH with mid-log 
BCG have shown that Dpp and Opp transporters in the cell membrane of the bacteria uptake 
glutathione, or uptake cy-gly. These two components can be attributed to the toxicity of 
glutathione (8).  
 
Nevertheless, no studies have been performed to determine the effects of GSH on NRP BCG. 
We performed a growth study over five days to evaluate the effect of GSH on the growth of NRP 
BCG. Our study revealed that unexposed NRP BCG remained in NRP and no conversion to mid-
logarithmic growth was observed. The maximum OD600 obtained and maintained was 
approximately 0.135. Similarly, NRP BCG exposed to 4 mM GSH revealed no changes in 
growth, or exit from the NRP state. The maximum OD600 of 4 mM GSH exposed NRP BCG was 
0.135. (Figure 1b). The inhibition and viability assays performed for unexposed and 4 mM GSH 
exposed NRP BCG show there are viable cells throughout the five days. In addition the viability 
indicates that there is no increase in the number of viable cells; suggesting that cells in both of 
these trials have remained in NRP. In relation to cell energetics, the initial concentration of free 
ATP in unexposed NRP BCG was 0.071 uM, and 0.024 uM in 4 mM GSH NRP BCG. 
Throughout the progression of the trail, unexposed NRP BCG did show increased levels of free 
ATP on days 3, 4, and 5; ranging between 0.746 uM and 1.698 uM. 4 mM GSH NRP BCG 
followed a similar increase in free intracellular ATP, but the concentrations ranged between 
0.241 uM and 0.406 uM. This accumulation of ATP in the cell may be attributed to the 
regulation of the NRP state, ensuring the cells remain in NRP. Also, when the cells are in the 
NRP they have decreased metabolism, suggesting that this basal amount of ATP is necessary to 
keep the cell alive in the low metabolic state. The ATP assay was performed to confirm that the 
free ATP present in mid-log BCG is significantly greater than that in NRP BCG. Also, by 
evaluating the free ATP in mid-log and NRP determined whether the induced NRP state was 
maintained over the five days.     
 
Our most significant findings reveal an unexpected growth of NRP BCG upon exposure to 8 mM 
GSH over five days. On Days 1, 2, and 3 the optical density remains within a standard deviation 
of 0.100. On Day 4, the optical density of the 8 mM GSH NRP BCG average increases to 0.207; 
a two fold increase in cell density. Furthermore, on Day 5, the average optical density increased 
to 0.398, also by a factor of two. This data presents an enigma as to how the bacteria are able to 
exit the NRP state, and enter active mid-logarithmic growth. Cell viability assays performed on 
NRP BCG revealed a ten fold lower number of cells in comparison mid-logarithmic bacterial 
cells. This is consistent with the models developed to explain the relative abundance of bacterial 
cells in active growth, and lack of active replication in latent mycobacteria (39). On Day 5, the 
viability assay (Figure 2b) indicates an increase in the number of CFU for unexposed, 4 mM 
GSH, and 8 mM GSH exposed NRP BCG. Upon normalization of the data for an OD600 of 0.100 
(Figure 2c), the data shows there are viable cells in unexposed and 4 mM GSH NRP BCG. Thus, 
unexposed and 4 mM GSH BCG does not exit the NRP state. In contrast, the normalization of 8 
mM GSH NRP BCG shows an approximate two fold decrease in the number of viable NRP 
mycobacteria. This data suggests that 8 mM GSH stimulates the transition from the NRP state to 
active mid-logarithmic growth. Once the mycobacteria have entered mid-log growth, 8 mM GSH 
acts to simultaneously kill the BCG. This killing is consistent with the killing data presented in 
our mid-log trials. In order to substantiate this claim, the energetics of the NRP BCG were 
evaluated over the five days. NRP mycobacteria exposed to 8 mM GSH showed to have basal 
free ATP levels of 0.016 – 0.045 uM. An increase in free ATP to 0.197 uM is noted on Day 3. 
Quantitatively, this is approximately a ten-fold increase in free ATP. On days 4 and 5, the 
intracellular free ATP levels returned to the basal as reported on days 1 and 2. This data supports 
the NRP exit because on Day 3, the increase in free intracellular ATP could potentially indicate 
that the cells are increasing their metabolic needs, in addition to various other cellular regulatory 
processes, to exit the NRP state. On days 4 and 5 the ATP levels return back to normal because 
this ATP is being utilized. However, on Day 5, it is hypothesized that the cells are in mid-
logarithmic growth, and 8 mM GSH acts to kill the mycobacteria; thus explaining the decreased 
free intracellular ATP levels.  
 
Previously, it has been hypothesized that GSH acts to create an oxidative imbalance within the 
mycobacterial cell, resulting in cell death (7). Currently, thiol HPLC analysis studies are being 
performed to determine the overall mycobacterial oxidative state of mid-log BCG exposed to 8 
mM GSH. The results from the NRP HPLC mycothiol analysis (Figure 4d), show on Day 4 a 
decrease in mycothiol concentration in 8 mM GSH NRP BCG cells. This decrease in mycothiol 
may be suggestive of a mechanism or response from exposure to GSH, leading to exit from the 
NRP state. However, no studies have been performed to evaluate whether the changes in the 
oxidative state of the NRP cytoplasm facilitate the exit from the NRP state.   
 
In order to fully evaluate the exit from NRP, the DosR regulation mechanism must be taken into 
account. Over the five days, the design of the protocol exposes the bacteria to a minimal, but 
uncalculated low concentration of oxygen. In order to maintain a hypoxic environment, sterile 
glass beads are added to reduce the headspace of free available oxygen in each culture tube, 
consistently over five days. Other procedures use more advanced molecular techniques to ensure 
that the mycobacteria remain in the NRP state by exposing them to low non-toxic concentrations 
of CO or NO (38). These molecules occupy the binding site of the DosR system, initiating and 
‘locking’ the transition into latency. Once bound, due to binding affinities, these molecules 
cannot be displaced, even in the presence of environmental oxygen. When manipulating the 
Wayne model for NRP, latency is achieved by extended non-shaking incubation, which 
eventually creates an anoxic environment through activation of the DosR regulon. When no 
oxygen molecules are eventually binding onto the DosR binding site, the latency genes are 
successively upregulated – inducing NRP. The introduction of low concentrations of oxygen can 
potentially allow binding to the DosR system at the heme group of DosT, reversing the process, 
and promoting exit from the NRP state. We hypothesize that the introduction of low 
concentrations of oxygen coupled with the activity of GSH (although unknown) induces exit 
from the NRP state. Furthermore, these results suggest that GSH can act or mimic a direct or 
indirect inducer for pathways associated with the regulation of the NRP state. 
 
Influence of GSSG/GSNO on Mid-log and NRP BCG 
The oxidized form of glutathione (GSSG) was also tested against mid-log and NRP BCG over 
five days to assess the impact of the compound on both cell stages. Mid-log BCG exposed to 4 
and 8 mM GSSG presented data similar to that of mid-log BCG exposed to GSH (Figure 5a). 
The growth curve, cell viability assay, and intracellular ATP assay have collectively confirmed 
that that GSSG inhibits cell growth, but is not able to kill the cells.  
 
NRP BCG exposed to 4 and 8 mM GSSG revealed no deviation in the growth curve in 
comparison to unexposed NRP BCG (Figure 5b). Over the five day trial period, the OD600 
increased from 0.100 (Day 1) to 0.249 (Day 5) for all three sample types. The cell viability assay 
results show there are similar cell units in each sample progressively over the five days (Figure 
6b). These data are indicative of neither bacterial growth stimulation nor killing.  
 
Growth studies, cell viability assays, and cell energetic assays were performed for mid-log and 
NRP BCG exposed to 4 and 8 mM GSNO. However, due to similarity of results with mid-log 
and NRP BCG exposed to GSSG, the data is not presented. Similar to that of mid-log BCG, 
GSNO showed to inhibit the growth over five days; killing due to exposure was not confirmed. 
Also, NRP BCG exposed to GSNO showed to have no deviation in results when compared to 
unexposed NRP BCG.   
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Figure Legends 
 
Figure 1a. Growth Curve of Mid-log BCG Exposed to GSH. The mid-log BCG GSH growth 
curve shows upon exposure to 8 mM GSH over five days, the OD600 does not exceed 0.25. 
Unexposed mycobacteria reach a maximum OD600 of 0.80 over five days. No significant 
deviations are noted for mycobacteria exposed to 4 mM GSH in comparison to unexposed 
mycobacteria.  
 
Figure 1b. Growth Curve of NRP BCG Exposed to GSH. Unexposed NRP BCG reached a 
maximum OD600 of 0.15 over five days. NRP BCG exposed to 4 mM GSH reached a maximum 
OD600 of 0.15, mimicking that of unexposed mycobacteria. Exposure to 8 mM GSH, NRP BCG 
increased in OD600 from 0.10 (Day 1) to 0.40 (Day 5).  
 
Figure 2a. Total Bacterial Cell Count of Mid-log BCG Exposed to GSH. This cell viability 
assay reports quantifiable CFU through day three for unexposed, 4 and 8 mM GSH exposed 
mycobacteria. On Day four and five, no viable CFU were quantitated upon exposure to 8 mM 
GSH. The lateral axis is scaled to a maximum of 7.0 x 109. This represents the number of viable 
cells in the overall culture tube; not normalized to OD600 of 0.1. 
 
Figure 2b. Total Bacterial Cell Count of NRP BCG Exposed to GSH. This data represents 
the CFU quantification for unexposed, 4 mM and 8 mM GSH NRP BCG over five days. The 
data here is scaled to a maximum of viable cells present in the culture tube over five days. Note 
the lateral axis of the graph to be 6.0 x 108 (This is 10 fold smaller than that of Figure 2a). 
Primary region of focus is Day 5, where are substantially more viable bacteria present.  
 
Figure 2c. Normalization of NRP BCG Exposed to GSH on Day 5 to OD600 = 0.1. 
Normalization of Day 5 data from Figure 2b is shown, to determine the number of viable CFU at 
an OD600 of 0.1. This data is shown for comparison reasons to determine the number of viable 
bacterial cells present in the 8 mM GSH NRP BCG on Day 5 as shown in Figure 2b. Note that 
the later axis of this graph extends to 6.0 x 108. 
 
Figure 3a. Total Concentration of Free Intracellular ATP In Mid-log BCG Exposed to 
GSH. The results shown here represent the free intracellular cytoplasmic concentration of ATP 
in mid-log BCG over five days. Unexposed BCG had a maximum concentration of 1.38 µM over 
five days. BCG exposed to 8 mM GSH resulted in a maximum ATP concentration of 2.28 µM on 
Day four. On Day five, the intracellular ATP concentration of 8 mM exposed BCG decreased to 
0.78 µM. 4 mM exposed BCG reached a maximum intracellular ATP concentration of 0.88 µM 
on Day two. All data present represents cell cultures normalized to OD600 0.1.  
 
Figure 3b. Total Concentration of Free Intracellular ATP In NRP BCG Exposed to GSH. 
Intracellular cytoplasmic ATP concentration for unexposed NRP BCG increased to a maximum 
of 1.70 µM on Day three. NRP BCG exposed to 4 mM GSH showed to have increased 
concentrations of intracellular ATP; 0.4 µM between Days three to five. NRP BCG exposed to 8 
mM GSH did not reveal a significant increase in intracellular ATP over the five-day period. All 
data present represents cell cultures normalized to OD600 0.1. 
 
Figure 4a. HPLC Mycothiol Analysis of NRP BCG Control on Day 1. This chromatogram 
shows the thiol separation of Day 1 bacterial cells for unexposed bacteria, normalized to an 
OD600 of 0.1. This sample was separated using 0.25% Acetic Acid (pH of 4.2). The average 
retention times for the two regions are 12:36 minutes, and 18:52 minutes. Regions after 30 
minutes are ghost peaks consistent with the media and other possible compounds. Regions of 
interest include Region 2 (Cys-Gly/L-Cys) and Region 3 (Mycothiol). The average retention 
time for Region 2 is 12.36 minutes; and for Region 3 it is the average retention time is 18:52 
minutes.  
 
Figure 4b. HPLC Mycothiol Analysis of NRP BCG Control on Day 5. The present 
chromatogram represents thiol separation of unexposed NRP BCG on Day 5, normalized to an 
OD600 of 0.1. This sample was analyzed using 0.25% Acetic Acid (pH of 4.2). The regions on 
interest include Region 2 (Cys-Gly/L-Cys) and Region 3 (Mycothiol). The average retention 
times for the two regions are 12:36 minutes, and 18:52 minutes. Regions after 30 minutes are 
ghost peaks consistent with the media and other possible compounds. 
 
HPLC Analysis of Cys-Gly, GSH, and MSH in NRP BCG Exposed to GSH on Day 5. NRP 
BCG exposed to 8 mM GSH are separated using the HPLC thiol analysis method above. This 
chromatogram represents the separation of exposed NRP BCG using 0.25% Acetic Acid (pH 
4.2). The sample was normalized to OD600 of 0.1. The average retention times for the two 
regions are 12:36 minutes, and 18:52 minutes. Regions after 30 minutes are ghost peaks 
consistent with the media and other possible compounds. Regions of interest include 2 (Cys-
Gly/L-Cys), 2a (GSH/Cys-Gly/L-Cys), and 3 (Mycothiol). The average retention times for the 
three regions are 12:36 minutes, 14:55 minutes, and 18:52 minutes.  
 
Figure 4d. Changes In the Amount of MSH Present In NRP BCG Exposed to GSH Over 5 
Days. This graph plots the average areas of Region 3 (Mycothiol) over five days to assess the 
increase or decrease in cellular concentrations. The red line represents mycothiol concentrations 
in 8 mM GSH exposed cells, while the blue represent the average mycothiol concentration 
change over five days.  
 
Figure 5a. Growth Curve of Mid-log BCG exposed to GSSG. The mid-log BCG GSSH 
growth curve shows upon exposure to 8 mM GSH over five days, the OD600 does not exceed 
0.24. Unexposed mycobacteria reach a maximum OD600 of 0.77 over five days. No significant 
deviations are noted for mycobacteria exposed to 4 mM GSH in comparison to unexposed 
mycobacteria. OD600 for 4 mM GSSG exposed does not exceed 0.31.  
 
Figure 5b. Growth Curve of NRP BCG exposed to GSSG. Unexposed NRP BCG reached a 
maximum OD600 value of 0.23, over five days. NRP BCG exposed to 4 mM GSSG increased to a 
maximum OD600 of 0.24 over five days. 8 mM GSSG NRP BCG showed a maximum increase in 
OD600 to 0.28 over the five-day period. These data show that there is no significant deviation 
between unexposed, 4, and 8 mM GSSG exposed NRP BCG. 
 
Figure 6a. Total Bacterial Cell Count of Mid-log BCG Exposed to GSSG. This cell viability 
assay reports quantifiable CFU for unexposed, 4 and 8 mM GSSG exposed mid-log 
mycobacteria over five days. There is no significant deviation for the number of CFU present for 
unexposed, 4, and 8 mM GSSG samples. All data present represent cell cultures normalized to an 
OD600 of 0.1. 
 
Figure 6b. Total Bacterial Cell Count of NRP BCG Exposed to GSSG. This NRP BCG cell 
viability figure shows the quantization of CFU for unexposed, 4, and 8 mM GSSG. Over the 
five-day period, there is no significant difference in the number of CFU between all three trial 
conditions. All data present represent cell cultures normalized to an OD600 of 0.1. 
 
Figure 7a. Total Concentration of Free Intracellular ATP In Mid-log BCG Exposed to 
GSH. The results shown here represent the free intracellular cytoplasmic concentration of ATP 
in mid-log BCG over five days. Unexposed BCG had a maximum concentration of 1.31 µM 
(Day 4) over five days. BCG exposed to 8 mM GSH resulted in a maximum ATP concentration 
of 2.10 µM on Day 4. 4 mM exposed BCG reached a maximum intracellular ATP concentration 
of 1.72 µM on Day 4. No statistical variation is noted in the data shown for unexposed, 4, and 8 
mM GSSH exposed bacteria. All data present represents cell cultures normalized to OD600 0.1.  
 
Figure 7b. Total Concentration of Free Intracellular ATP In NRP BCG Exposed to GSH. 
The results shown here represent the free intracellular cytoplasmic concentration of ATP in NRP 
BCG over five days. Unexposed BCG had a maximum concentration of 0.70 µM (Day 4) over 
five days. BCG exposed to 8 mM GSH resulted in a maximum ATP concentration of 1.08 µM on 
Day 4. 4 mM exposed BCG reached a maximum intracellular ATP concentration of 0.89 µM on 
Day 4. No statistical variation is noted in the data shown for unexposed, 4, and 8 mM GSSH 
exposed bacteria. All data present represents cell cultures normalized to OD600 0.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1a. Growth Curve of Mid-log BCG Exposed to GSH. 
 
 
 
 
Figure 1b. Growth Curve of NRP BCG Exposed to GSH.  
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Figure 2a. Total Bacterial Cell Count of Mid-log BCG Exposed to GSH.  
 
 
Figure 2b. Total Bacterial Cell Count of NRP BCG Exposed to GSH. 
 
 
Figure 2c. Normalization of NRP BCG Exposed to GSH on Day 5 to OD600 = 0.1. 
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Figure 3a. Total Concentration of Free Intracellular ATP In Mid-log BCG Exposed to 
GSH. 
 
 
 
 
Figure 3b. Total Concentration of Free Intracellular ATP In NRP BCG Exposed to GSH. 
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Figure 4a. HPLC Mycothiol Analysis of NRP BCG Control on Day 1.  
 
 
 
 
 
 
Figure 4b. HPLC Mycothiol Analysis of NRP BCG Control on Day 5. 
 
 
 
 
 
Figure 4c. HPLC Analysis of Cys-Gly, GSH, and MSH in NRP BCG Exposed to GSH on 
Day 5. 
 
 
Figure 4d. Changes In the Amount of MSH Present In NRP BCG Exposed to GSH Over 5 
Days. 
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Figure 5a. Growth Curve of Mid-log BCG exposed to GSSG.   
 
 
Figure 5b. Growth Curve of NRP BCG exposed to GSSG.
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
1 
Day 1 Day 2 Day 3 Day 4  Day 5 
O
pt
ic
al
 D
en
si
ty
 o
f B
C
G
 a
t  
60
0 
nm
 
0 mM GSSG 
4 mM GSSG 
8 mM GSSG 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
1 
Day 1 Day 2 Day 3 Day 4 Day 5 
O
pt
ic
al
 D
en
si
ty
 o
f B
C
G
 a
t 6
00
 n
m
 
0 mM GSSG 
4 mM GSSG 
8 mM GSSG 
 
Figure 6a. Total Bacterial Cell Count of Mid-log BCG Exposed to GSSG.  
 
 
 
 
Figure 6b. Total Bacterial Cell Count of NRP BCG Exposed to GSSG. 
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Figure 7a. Total Concentration of Free Intracellular ATP In Mid-log BCG Exposed to 
GSH. 
 
 
 
 
Figure 7b. Total Concentration of Free Intracellular ATP In NRP BCG Exposed to GSH. 
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